MedTrace Logo

Near-Infrared Spectroscopy for Blood Glucose Measurements

NCT01168115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-07-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the performance of a near-infrared transmission measurement in blood samples collected from healthy volunteers. We propose that NIR spectroscopic blood glucose measurements in healthy patients are as accurate as handheld glucometers and a Yellow Springs Instrument (YSI). We will also evaluate in vitro blood samples spiked with pharmacological interferents to test if the spectroscopic glucose measurement is affected by common medications.

Conditions

  • Healthy

Sponsors & Collaborators

  • Luminous Medical

    collaborator INDUSTRY

  • InLight Solutions

    lead INDUSTRY

Principal Investigators

  • Mark Rohrscheib, M.D. · UNMHSC

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01168115 on ClinicalTrials.gov